Intervention
clinical observation
ClinicalTrials.gov intervention label
Advertisement
Clinical trials
10 shownTreatment in Preventing Anal Cancer in Patients With HIV and Anal High-Grade LesionsNCT02135419 · 2014-09-24
COMPLETEDStudying Changes in Breast Density in Patients With Early-Stage Breast Cancer Treated With Metformin Hydrochloride or Placebo on CAN-NCIC-MA.32NCT01666171 · 2012-08-01
UNKNOWNInfrared Coagulator Ablation or Observation in Preventing Anal Cancer in HIV-Positive Patients With Anal NeoplasiaNCT01164722 · 2011-04-01
COMPLETEDPemetrexed Disodium/Observation in Treating Patients W/ Malignant Pleural Mesothelioma w/Out Progressive Disease After 1st Line ChemotherapyNCT01085630 · 2010-04-01
COMPLETEDRadiation Therapy or Observation After Chemotherapy in Treating Patients With Stage IV Non-Small Cell Lung CancerNCT00776100 · 2008-10-01
TERMINATEDRadiation Therapy in Treating Patients With Non Small Cell Lung Cancer That Has Been Completely Removed by SurgeryNCT00410683 · 2007-02-01
UNKNOWNIncidence of Blood Clots in Patients Undergoing Chemotherapy for Solid TumorsNCT00433602 · 2006-11-01
COMPLETEDNatural History Study of Fungal Infections of the Blood in Patients With Cancer or in Patients Who Have Undergone a Stem Cell TransplantNCT00445952 · 2005-02-01
COMPLETEDCalcitriol and Dexamethasone Before Radical Prostatectomy in Treating Patients With Localized Adenocarcinoma (Cancer) of the ProstateNCT00084864 · 2002-09-01
TERMINATEDSWOG-9346, Hormone Therapy in Treating Men With Stage IV Prostate CancerNCT00002651 · 1995-05-01
COMPLETEDCommon conditions
Prostate Cancer3Anal Cancer2Breast Cancer2Lung Cancer2Cancer1Colorectal Cancer1Gastric Cancer1High-grade Squamous Intraepithelial Lesion1HIV Infection1Human Papilloma Virus Infection1Malignant Mesothelioma1Neoplasm of Uncertain Malignant Potential1Non-small Cell Lung Cancer1Nonneoplastic Condition1Ovarian Cancer1Pancreatic Cancer1Precancerous Condition1Thromboembolism1
Leading sponsors
Trial status mix
COMPLETED6
TERMINATED2
UNKNOWN2
Phase mix
PHASE34
PHASE23
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.